TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
neuroblastoma, Neuroblastoma: Click to Expand ⟱
Neuroblastoma is a type of cancer that develops in immature nerve tissue, usually affecting kids under age 5.
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
BC, |
SkBr3 |
|
|
|
- |
Review, |
neuroblastoma, |
SK-N-SH |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
PDH↑, TumCG↓, ROS↑, AMPK↑, EGR4↓, Half-Life↓, BioAv↝, *GSH↑, *IronCh↑, *ROS↓, *antiOx↑, *neuroP↑, *Ach↑, *lipid-P↓, *IL1β↓, *IL6↓, TumCP↓, FDG↓, Apoptosis↑, AMPK↑, mTOR↓, EGFR↓, TumCI↓, TumCMig↓, *memory↑, *BioAv↑, *BioAv↝, *other↓, *other↝, *Half-Life↓, *BioAv↑, *ChAT↑, *GlucoseCon↑,
| - |
in-vitro, |
neuroblastoma, |
NA |
|
|
|
CSCs↓, CD133↓, β-catenin/ZEB1↓, n-MYC↓, SOX2↓, NOTCH2↓, Nestin↓, TumCCA↑, TumCP↓, CDK1↓, Cyc↓, Apoptosis↑, Bax:Bcl2↑, NCAM↓, MMP2↓, MMP9↓, *Smad1↑, *HSP70/HSPA5↑, *LAMs↑,
| - |
Review, |
neuroblastoma, |
SK-N-BE |
|
|
|
Apoptosis↑, TumCP↓, TumCMig↓, MMP↓, ROS↑, ETC↓, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, eff↓, TumCG↓, Ki-67↓, PCNA↓,
| - |
in-vitro, |
neuroblastoma, |
NXS2 |
|
|
|
TumCP↓, Casp8↑, Casp9↑, Ca+2↑,
| - |
in-vitro, |
Liver, |
HUH7 |
|
|
|
- |
in-vitro, |
Liver, |
Hep3B |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
neuroblastoma, |
SH-SY5Y |
|
|
|
- |
in-vitro, |
Nor, |
IMR90 |
|
|
|
TumCP↓, eff↑, ROS↑, eff↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 3,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ETC↓, 1, MMP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 2, FDG↓, 1, PDH↑, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 3, BAX↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 1, cl‑Casp3↑, 1, Casp8↑, 1, Casp9↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, Cyc↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CD133↓, 1, CSCs↓, 1, mTOR↓, 1, n-MYC↓, 1, Nestin↓, 1, NOTCH2↓, 1, SOX2↓, 1, TumCG↓, 2,
Migration(tgid=13) ⓘ
Ca+2↑, 1, Ki-67↓, 1, MMP2↓, 1, MMP9↓, 1, NCAM↓, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 5, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↓, 1, EGR4↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, eff↓, 2, eff↑, 1, Half-Life↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, Ki-67↓, 1,
Total Targets: 43
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, GSH↑, 1, lipid-P↓, 1, ROS↓, 1,
Metal & Cofactor Biology(tgid=2) ⓘ
IronCh↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
GlucoseCon↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
Ach↑, 1, other↓, 1, other↝, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP70/HSPA5↑, 1,
Migration(tgid=13) ⓘ
LAMs↑, 1, Smad1↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, IL6↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
ChAT↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 2, BioAv↝, 1, Half-Life↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
memory↑, 1, neuroP↑, 1,
Total Targets: 21
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:40 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page